Case Report
Rheumatoid Arthritis, Kartagener’s Syndrome, and Hyperprolactinemia: Who Started It?
Table 1
Summary of reported cases and patient characteristics.
| Case report | Race | Age | Sex | Other comorbidities | RF or ACPA | HLA type | Erosions | Other X-ray findings | Treatment received |
| Kawasaki et al. 2000 [6] | Japan | 11 | M | None | Negative | — | — | — | MTX, Prednisolone, and NSAIDS (doses not mentioned) and then later MTX changed to Bucillamine |
| Riente et al. 2001 [7] | Italy | 60 | F | DM, HTN, heart failure | Positive
| A1, B44, B51, DRB111 DRB116 DRB3, DRB5 | No | Symmetric narrowing of MCP + PIP with juxta-articular osteoporosis | Initially Chloroquine 500 mg/day orally + Methylprednisolone 4 mg/d Then Gold IM, low dose steroids + antibiotics |
|
Rébora et al. 2006 [9] | Argentina | 38 | F | None | Positive
| (i) A1, B8, B57 (ii) HLA DR not studied | Yes | Narrowing at the wrists + 3rd MCPs bilaterally with juxta-articular osteopenia | Initially SSZ 1.5 g per day + NSAIDS Later Chloroquine 200 mg and then HCQ 400 mg daily Subsequently shifted to MTX 15 mg/day |
| Younes et al. 2006 [8] | Tunisia | 35 | F | None | Positive
| — | Yes | Narrowing at the MCPs + 2nd & 3rd PIPs | Indomethacin 100 mg daily, Prednisolone 10 mg orally daily and MTX 10 mg weekly later increased to 15 mg weekly |
| Takasaki et al. 2014 [10] | Japan | 47 | F | Periodontitis, smoker | Positive
| — | Yes | Joint destruction in the RT thumb MCP + LT thumb MCP and PIP | MTX 12 mg weekly, Tacrolimus 2 mg/daily, Prednisone 4 mg daily Later shifted to Etanercept 50 mg/week + tacrolimus tapered off |
| Our patient | Saudi Arabia | 18 | F | — | Positive | — | No | Normal | MTX 12.5 mg PO weekly gradually increased until 20 mg weekly + Prednisolone 15 mg orally daily gradually tapered off |
|
|
MTX = Methotrexate, HCQ = Hydroxychloroquine, and SSZ = sulfasalazine.
|